A COPD Data Registry for Participants With Frequent Exacerbations (AIREIC)

Roche

Status: Begins enrollment in 3 months

Conditions: COPD

Study type: Observational

Funder types: Industry

Identifiers

NCT07059273

BA45495

Details and patient eligibility

About

This registry will collect data on COPD, including the course of disease, treatment patterns, and potential new therapies. The registry will also track the experience of participants and caregivers in clinical practice.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of COPD for at least 12 months
• On stable, standard of care (SoC) COPD maintenance therapy
• Have experienced at least 2 exacerbations (moderate or severe) in the last 12 months, with one of them occurring while on SoC therapy

Exclusion criteria

• In palliative treatment
• Participating in any interventional drug trials

Trial design

3,000 participants in 1 patient group

COPD Arm

Description:

Participants with COPD with frequent exacerbations will be followed from the date of enrollment until death, loss to follow up, withdrawal of consent, or the end of the follow-up period, for up to 3 years.